Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Calithera Biosciences stock opened at $0.01 on Wednesday. The stock’s 50 day simple moving average is $0.02 and its two-hundred day simple moving average is $0.02. Calithera Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.13.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.